Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - NASDAQ:BWAY - US10501L1061 - ADR

15.87 USD
-0.14 (-0.87%)
Last: 11/14/2025, 2:51:41 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BWAY. BWAY was compared to 189 industry peers in the Health Care Equipment & Supplies industry. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability. BWAY is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make BWAY suitable for value and growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BWAY had positive earnings in the past year.
In the past year BWAY had a positive cash flow from operations.
BWAY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of BWAY (4.79%) is better than 80.95% of its industry peers.
Looking at the Return On Equity, with a value of 7.84%, BWAY belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.83%, BWAY is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROIC 1.83%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BWAY has a better Profit Margin (11.60%) than 85.71% of its industry peers.
With a decent Operating Margin value of 4.05%, BWAY is doing good in the industry, outperforming 68.25% of the companies in the same industry.
The Gross Margin of BWAY (74.52%) is better than 85.19% of its industry peers.
BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
Compared to 5 years ago, BWAY has more shares outstanding
The debt/assets ratio for BWAY is higher compared to a year ago.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.25 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY has a Altman-Z score of 4.25. This is in the better half of the industry: BWAY outperforms 76.19% of its industry peers.
BWAY has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
BWAY has a better Debt to FCF ratio (0.33) than 92.59% of its industry peers.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Altman-Z 4.25
ROIC/WACC0.21
WACC8.74%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BWAY has a Current Ratio of 3.51. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY's Current ratio of 3.51 is fine compared to the rest of the industry. BWAY outperforms 65.61% of its industry peers.
A Quick Ratio of 3.34 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Quick ratio (3.34) than 70.90% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 3.34
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 223.65% over the past year.
BWAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.04%.
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)223.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%-65.32%

3.2 Future

Based on estimates for the next years, BWAY will show a very strong growth in Earnings Per Share. The EPS will grow by 53.27% on average per year.
The Revenue is expected to grow by 19.29% on average over the next years. This is quite good.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.56, BWAY is valued correctly.
Based on the Price/Earnings ratio, BWAY is valued cheaper than 84.66% of the companies in the same industry.
BWAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.91.
With a Price/Forward Earnings ratio of 10.52, the valuation of BWAY can be described as very reasonable.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 92.59% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.57, BWAY is valued rather cheaply.
Industry RankSector Rank
PE 15.56
Fwd PE 10.52
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than 65.08% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 90.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.1
EV/EBITDA 58.51
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 53.27% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%

0

5. Dividend

5.1 Amount

No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield N/A

BRAINSWAY LTD-ADR

NASDAQ:BWAY (11/14/2025, 2:51:41 PM)

15.87

-0.14 (-0.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/bmo
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners5.13%
Inst Owner Change-4.83%
Ins Owners16.62%
Ins Owner ChangeN/A
Market Cap301.59M
Revenue(TTM)41.02M
Net Income(TTM)5.34M
Analysts85.71
Price Target0.11 (-99.31%)
Short Float %0.95%
Short Ratio2.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.07%
PT rev (3m)35.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 10.52
P/S 6.54
P/FCF 16.1
P/OCF 13.02
P/B 4.43
P/tB 4.43
EV/EBITDA 58.51
EPS(TTM)1.02
EY6.43%
EPS(NY)1.51
Fwd EY9.5%
FCF(TTM)0.99
FCFY6.21%
OCF(TTM)1.22
OCFY7.68%
SpS2.43
BVpS3.59
TBVpS3.59
PEG (NY)0.26
PEG (5Y)N/A
Graham Number9.07
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROCE 2.17%
ROIC 1.83%
ROICexc 19.56%
ROICexgc 19.56%
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
FCFM 40.64%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Debt/EBITDA 1.37
Cap/Depr 229.33%
Cap/Sales 9.62%
Interest Coverage 11.81
Cash Conversion 609.66%
Profit Quality 350.45%
Current Ratio 3.51
Quick Ratio 3.34
Altman-Z 4.25
F-Score4
WACC8.74%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)223.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.11%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%-65.32%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


What is the valuation status for BWAY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


What is the valuation of BRAINSWAY LTD-ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRAINSWAY LTD-ADR (BWAY) is 15.56 and the Price/Book (PB) ratio is 4.43.